STOCK TITAN

[Form 4] DAVITA INC. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

DaVita Inc. Chief Legal & Public Affairs Officer Kathleen Alyce Waters reported two stock awards of common shares. On March 10, 2026, she acquired 4,829 shares of DaVita common stock at a price of $0.00 per share and separately acquired 51,330 additional shares, also at $0.00 per share.

Footnotes explain these shares were received upon satisfaction of criteria for performance stock units granted on March 15, 2022 and March 15, 2023, with 100% of each award scheduled to vest on March 15, 2026. Following these acquisitions, Waters directly holds 155,277 shares of DaVita common stock.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Waters Kathleen Alyce

(Last) (First) (Middle)
C/O DAVITA INC.
2000 16TH STREET

(Street)
DENVER CO 80202

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
DAVITA INC. [ DVA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Legal & Pub. Affairs Off
3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/10/2026 A 4,829(1) A $0 103,947 D
Common Stock 03/10/2026 A 51,330(2) A $0 155,277 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Shares received upon the satisfaction of criteria underlying the award of performance stock units granted to the Reporting Person on March 15, 2022, of which 100% will vest on March 15, 2026.
2. Shares received upon the satisfaction of criteria underlying the award of performance stock units granted to the Reporting Person on March 15, 2023, of which 100% will vest on March 15, 2026.
Remarks:
/s/ Stephanie N. Berberich, Attorney-in-Fact 03/12/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did DaVita (DVA) report for Kathleen Alyce Waters?

DaVita reported that Chief Legal & Public Affairs Officer Kathleen Alyce Waters acquired two blocks of common stock. She received 4,829 shares and 51,330 shares at zero cost as part of performance stock unit awards tied to previously granted compensation packages.

How many DaVita (DVA) shares does Kathleen Alyce Waters hold after this Form 4?

After the reported stock awards, Kathleen Alyce Waters directly holds 155,277 DaVita common shares. This total reflects her position following the March 10, 2026 grants, as disclosed in the filing’s post-transaction ownership field for the larger 51,330-share award.

What was the price per share for Kathleen Alyce Waters’ DaVita stock awards?

Both awards to Kathleen Alyce Waters were reported at a price of $0.00 per share. This indicates they were compensation-related grants of common stock, not open-market purchases, and arose from performance stock unit awards rather than cash-funded transactions.

What are the vesting terms of Kathleen Alyce Waters’ DaVita performance stock units?

The filing states that shares were received upon satisfaction of criteria for performance stock units granted in 2022 and 2023. For both awards, 100% of the performance stock units are scheduled to vest on March 15, 2026, according to the footnote disclosures.

Were Kathleen Alyce Waters’ DaVita (DVA) transactions open-market buys or compensation awards?

The transactions are classified as awards or other acquisitions, not open-market purchases. Code “A” and a $0.00 price per share, along with footnotes referencing performance stock units, show these were compensation-related grants rather than discretionary stock purchases.
Davita Inc

NYSE:DVA

View DVA Stock Overview

DVA Rankings

DVA Latest News

DVA Latest SEC Filings

DVA Stock Data

10.23B
33.09M
Medical Care Facilities
Services-misc Health & Allied Services, Nec
Link
United States
DENVER